Submit A Case
CPMS
menu
Search
A11Y
Accessibility
Rare Diseases Working Groups
Hereditary Haemorrhagic Telangiectasia Working Group (HHT-WG)
Heritable Thoracic Aortic Diseases Working Group (HTAD-WG)
Medium Sized Arteries Working Group (MSA-WG)
Neurovascular Diseases Working Group (NEUROVASC-WG)
Pediatric and Primary Lymphedema Working Group (PPL-WG)
Vascular Anomalies Working Group (VASCA-WG)
Follow us
Contact us
Contact vascern
Goals and Expertise
About VASCERN
Our missions
Funding
Goals for the future
Network
Experts
Working Groups
European Patient Advocacy Group (ePAG)
Coordination Project Team
Partnerships
Clinical Trials and Research
Clinical Trials/Observational Studies
Research Publications
Clinical Decision Support Tools
Clinical Practice Guidelines
Outcome Measures
Do’s and Don’ts
Expert consensus statements
Patient Pathways
Registry
Registry
Sub-registries
Training and Education
Interactive Learning Modules
Pills of Knowledge
Webinars
EU Trainings
VASCERN Exchange Program
VASCERN Summer School – ERASMUS+
News & Events
Events
News
Newsletter
Site Map
VASCERN Resources in all EU languages
All resources
IT Tools
ERN COLLABORATIVE PLATFORM (ECP)
CLINICAL PATIENT MANAGEMENT SYSTEM (CPMS)
VASCERN Mobile App
Search ...
Type
Select a type
Working Group
Pages
Resources
News
Events
Date start
facebook
twitter
youtube
linkedin
Home
-
Resources
-
A mutation update on the LDS associated genes TGFB2/3 and SMAD2/3
March 28 2023
A mutation update on the LDS associated genes TGFB2/3 and SMAD2/3
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
Sitemap
Sitemap
